The Trade:Sell to Open the GILD Mar 6 2026 136/130 Put Vertical @ $2.17 Credit.
🔴 SELL TO OPEN Mar 06 2026 136 Put @ $4.38
🟢 BUY TO OPEN Mar 06 2026 130 Put @ $2.21
Trade Metrics: POP: 60.63% | Collect $217 per contract vs. a Max Risk of $383 (1.76:1).
The Why: Gilead remains a robust defensive play with consistent cash flows from its HIV portfolio and expanding opportunities in oncology, making this dip an attractive setup for income generation.
The Technicals: GILD is in a confirmed bullish trend across both 1M and 6M timeframes, currently consolidating near the $137 level; holding this support zone opens the path toward the $138.03 resistance level.
Management:⚠️ Warning: Earnings is scheduled for Feb 10, 2026, which may require active management.
Stop Loss:Buy to Close the trade at $4.34 (100% of credit received).
Take Profit:Buy to Close the trade at $1.09 (50% gain).
The Trade:Sell to Open the LIN Feb 20 2026 455/445 Put Vertical @ $4.10 Credit.
🔴 SELL TO OPEN Feb 20 2026 455 Put @ $11.30
🟢 BUY TO OPEN Feb 20 2026 445 Put @ $7.20
Trade Metrics: POP: 54.56% | Collect $410 per contract vs. a Max Risk of $590 (1.44:1).
The Why: Linde’s dominant position in industrial gases allows it to pass through costs effectively, creating a stable fundamental backdrop that supports a high-probability credit strategy.
The Technicals: The stock maintains a strong bullish trend and is currently hovering just above key support at $450; a successful defense of this level suggests a move back toward the $483 resistance.
Management:⚠️ Warning: Earnings is scheduled for Feb 05, 2026, which may require active management.
Stop Loss:Buy to Close the trade at $8.20 (100% of credit received).
Take Profit:Buy to Close the trade at $2.05 (50% gain).
The Trade:Buy to Open the HUM Feb 27 2026 260/305 Call Vertical @ $13.65 Debit.
🟢 BUY TO OPEN Feb 27 2026 260 Call @ $19.95
🔴 SELL TO OPEN Feb 27 2026 305 Call @ $6.30
Trade Metrics: POP: 37.62% | Pay $1,365 per contract vs. a Max Reward of $3,135 (2.3:1).
The Why: While the sector faces regulatory noise, the fundamental long-term thesis for managed care remains intact, and the current valuation compression offers a favorable risk/reward for a recovery rally.
The Technicals: Despite a recent mildly bearish 1M trend, the 6M trend remains bullish; the “Bullish Trend Following” signal identifies the current pullback to the $260 support zone as a prime buying opportunity.
Management:⚠️ Warning: Earnings is scheduled for Feb 11, 2026, which may require active management.
Stop Loss:Sell to Close the trade at $6.83 (50% loss).
Take Profit:Sell to Close the trade at $23.89 (75% gain).
Share this on